Genes (Nov 2020)

Preliminary Findings on CTG Expansion Determination in Different Tissues from Patients with Myotonic Dystrophy Type 1

  • Alfonsina Ballester-Lopez,
  • Emma Koehorst,
  • Ian Linares-Pardo,
  • Judit Núñez-Manchón,
  • Miriam Almendrote,
  • Giuseppe Lucente,
  • Andrea Arbex,
  • Carles Puente,
  • Alejandro Lucia,
  • Darren G. Monckton,
  • Sarah A. Cumming,
  • Guillem Pintos-Morell,
  • Jaume Coll-Cantí,
  • Alba Ramos-Fransi,
  • Alicia Martínez-Piñeiro,
  • Gisela Nogales-Gadea

DOI
https://doi.org/10.3390/genes11111321
Journal volume & issue
Vol. 11, no. 11
p. 1321

Abstract

Read online

Myotonic Dystrophy type 1 (DM1) is characterized by a high genetic and clinical variability. Determination of the genetic variability in DM1 might help to determine whether there is an association between CTG (Cytosine-Thymine-Guanine) expansion and the clinical manifestations of this condition. We studied the variability of the CTG expansion (progenitor, mode, and longest allele, respectively, and genetic instability) in three tissues (blood, muscle, and tissue) from eight patients with DM1. We also studied the association of genetic data with the patients’ clinical characteristics. Although genetic instability was confirmed in all the tissues that we studied, our results suggest that CTG expansion is larger in muscle and skin cells compared with peripheral blood leukocytes. While keeping in mind that more research is needed in larger cohorts, we have provided preliminary evidence suggesting that the estimated progenitor CTG size in muscle could be potentially used as an indicator of age of disease onset and muscle function impairment.

Keywords